SA81. Glutamatergic and GABAergic Disturbances in Individuals at Ultra-High Risk of Psychosis: Implications for Clinical and Functional Outcome

Por Wenneberg, Christina, Glenthøj, Birte Y., Broberg, Brian V., Glenthøj, Louise B., Kristensen, Tina D., Krakauer, Kristine, Rostrup, Egill, Nordentoft, Merete
Publicado no Schizophr Bull (2017)

SA90. Nonpharmacological Modulation of Cerebral White Matter Organization: A Systematic Review

Por Kristensen, Tina, Mandl, Rene, Jepsen, Jens R.M., Rostrup, Egill, Glenthøj, Louise B., Nordentoft, Merete, Glenthøj, Birte, Ebdrup, Bjørn H.
Publicado no Schizophr Bull (2017)

The FOCUS trial: cognitive remediation plus standard treatment versus standard treatment for patients at ultra-high risk for psychosis: study protocol for a randomised controlled t...

Por Glenthøj, Louise B, Fagerlund, Birgitte, Randers, Lasse, Hjorthøj, Carsten R, Wenneberg, Christina, Krakauer, Kristine, Vosgerau, Astrid, Gluud, Christian, Medalia, Alice, Roberts, David L, Nordentoft, Merete
Publicado no Trials (2015)

Social cognition in patients at ultra-high risk for psychosis: What is the relation to social skills and functioning?

Por Glenthøj, Louise B., Fagerlund, Birgitte, Hjorthøj, Carsten, Jepsen, Jens R.M., Bak, Nikolaj, Kristensen, Tina D., Wenneberg, Christina, Krakauer, Kristine, Roberts, David L., Nordentoft, Merete
Publicado no Schizophr Res Cogn (2016)